Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Xiamen Amoytop Biotech Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 5/6
Xiamen Amoytop Biotech has been growing earnings at an average annual rate of 46%, while the Biotechs industry saw earnings growing at 3.1% annually. Revenues have been growing at an average rate of 27.6% per year. Xiamen Amoytop Biotech's return on equity is 32.7%, and it has net margins of 27.6%.
Anahtar bilgiler
46.0%
Kazanç büyüme oranı
45.4%
EPS büyüme oranı
Biotechs Sektör Büyümesi | 11.3% |
Gelir büyüme oranı | 27.6% |
Özkaynak getirisi | 32.7% |
Net Marj | 27.6% |
Sonraki Kazanç Güncellemesi | 25 Oct 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 26% Jump Shows Its Popularity With Investors
Sep 19Investors Appear Satisfied With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Prospects As Shares Rocket 26%
Sep 19Is There An Opportunity With Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) 50% Undervaluation?
Jun 12Xiamen Amoytop Biotech (SHSE:688278) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 04Xiamen Amoytop Biotech Co., Ltd.'s (SHSE:688278) Share Price Could Signal Some Risk
Mar 25Gelir ve Gider Dağılımı
Xiamen Amoytop Biotech nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
30 Jun 24 | 2,387 | 658 | 1,179 | 265 |
31 Mar 24 | 2,226 | 600 | 1,126 | 234 |
31 Dec 23 | 2,100 | 555 | 1,058 | 229 |
30 Sep 23 | 1,843 | 456 | 951 | 190 |
30 Jun 23 | 1,716 | 356 | 921 | 174 |
31 Mar 23 | 1,601 | 314 | 867 | 166 |
31 Dec 22 | 1,527 | 287 | 840 | 149 |
30 Sep 22 | 1,466 | 254 | 852 | 124 |
30 Jun 22 | 1,378 | 243 | 832 | 93 |
31 Mar 22 | 1,262 | 204 | 772 | 83 |
31 Dec 21 | 1,132 | 181 | 698 | 80 |
30 Sep 21 | 1,043 | 168 | 629 | 86 |
30 Jun 21 | 904 | 142 | 552 | 79 |
31 Mar 21 | 822 | 128 | 506 | 76 |
31 Dec 20 | 794 | 117 | 503 | 74 |
30 Sep 20 | 762 | 98 | 495 | 57 |
30 Jun 20 | 771 | 95 | 495 | 57 |
31 Mar 20 | 771 | 86 | 505 | 52 |
31 Dec 19 | 730 | 64 | 485 | 50 |
30 Sep 19 | 665 | 58 | 441 | 50 |
31 Dec 18 | 448 | 16 | 319 | 38 |
31 Dec 17 | 323 | 5 | 255 | 18 |
31 Dec 16 | 280 | 29 | 203 | 9 |
Kaliteli Kazançlar: 688278 has a high level of non-cash earnings.
Büyüyen Kar Marjı: 688278's current net profit margins (27.6%) are higher than last year (20.7%).
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 688278's earnings have grown significantly by 46% per year over the past 5 years.
Büyüme Hızlandırma: 688278's earnings growth over the past year (85%) exceeds its 5-year average (46% per year).
Kazançlar vs. Sektör: 688278 earnings growth over the past year (85%) exceeded the Biotechs industry 10.1%.
Özkaynak Getirisi
Yüksek ROE: 688278's Return on Equity (32.7%) is considered high.